|
1
|
Rybicka M, Nakonieczna J, Stalke P and
Bielawski KP: Host response to the presence of Helicobacter spp.
DNA in the liver of patients with chronic liver diseases. Pol J
Microbiol. 60:175–178. 2011.PubMed/NCBI
|
|
2
|
Schistosomes, liver flukes and
Helicobacter pylori. In: IARC Working Group on the Evaluation of
Carcinogenic Risks to Humans; Lyon. 7–14 June 1994; IARC monographs
on the evaluation of carcinogenic risks to humans. World Health
Organization, International Agency for Research on Cancer; 61. pp.
1–241. 1994
|
|
3
|
Wedi B and Kapp A: Helicobacter pylori
infection in skin diseases: a critical appraisal. Am J Clin
Dermatol. 3:273–282. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pellicano R, Menard A, Rizzetto M and
Megraud F: Helicobacter species and liver diseases: association or
causation? Lancet Infect Dis. 8:254–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Farsak B, Yildirir A, Akyön Y, Pinar A, Oç
M, Böke E, Kes S and Tokgözoğlu L: Detection of Chlamydia
pneumoniae and Helicobacter pylori DNA in human atherosclerotic
plaques by PCR. J Clin Microbiol. 38:4408–4411. 2000.PubMed/NCBI
|
|
6
|
Ameriso SF, Fridman EA, Leiguarda RC and
Sevlever GE: Detection of Helicobacter pylori in human carotid
atheroscle-rotic plaques. Stroke. 32:385–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Danesh J, Koreth J, Youngman L, Collins R,
Arnold JR, Balarajan Y, McGee J and Roskell D: Is Helicobacter
pylori a factor in coronary atherosclerosis? J Clin Microbiol.
37:16511999.PubMed/NCBI
|
|
8
|
Nilsson I, Lindgren S, Eriksson S and
Wadstrom T: Serum antibodies to Helicobacter hepaticus and
Helicobacter pylori in patients with chronic liver disease. Gut.
46:410–414. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pellicano R, Leone N, Berrutti M, Cutufia
MA, Fiorentino M, Rizzetto M and Ponzetto A: Helicobacter pylori
seroprevalence in hepatitis C virus positive patients with
cirrhosis. J Hepatol. 33:648–650. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponzetto A, Pellicano R, Leone N, Berrutti
M, Turrini F and Rizzetto M: Helicobacter pylori seroprevalence in
cirrhotic patients with hepatitis B virus infection. Neth J Med.
56:206–210. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponzetto A, Pellicano R, Leone N, Cutufia
MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M and
Silengo L: Helicobacter infection and cirrhosis in hepatitis C
virus carriage: is it an innocent bystander or a troublemaker? Med
Hypotheses. 54:275–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Queiroz DM, Rocha AM, Rocha GA, Cinque SM,
Oliveira AG, Godoy A and Tanno H: Association between Helicobacter
pylori infection and cirrhosis in patients with chronic hepatitis C
virus. Dig Dis Sci. 51:370–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avenaud P, Marais A, Monteiro L, Le Bail
B, Bioulac Sage P, Balabaud C and Mégraud F: Detection of
Helicobacter species in the liver of patients with and without
primary liver carcinoma. Cancer. 89:1431–1439. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xuan SY, Li N, Qiang X, Zhou RR, Shi YX
and Jiang WJ: Helicobacter infection in hepatocellular carcinoma
tissue. World J Gastroenterol. 12:2335–2340. 2006.PubMed/NCBI
|
|
15
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
17
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iwatsuki S, Starzl TE, Sheahan DG,
Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B,
Selby R, et al: Hepatic resection versus transplantation for
hepatocellular carcinoma. Ann Surg. 214:221–228; discussion
228–229. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McPeake JR, O'Grady JG, Zaman S, Portmann
B, Wight DG, Tan KC, Calne RY and Williams R: Liver transplantation
for primary hepatocellular carcinoma: tumor size and number
determine outcome. J Hepatol. 18:226–234. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kensler TW, Roebuck BD, Wogan GN and
Groopman JD: Aflatoxin: a 50-year odyssey of mechanistic and
translational toxicology. Toxicol Sci. 120(Suppl 1): S28–S48. 2011.
View Article : Google Scholar :
|
|
21
|
Chuang SC, La Vecchia C and Boffetta P:
Liver cancer: Descriptive epidemiology and risk factors other than
HBV and HCV infection. Cancer Lett. 286:9–14. 2009. View Article : Google Scholar
|
|
22
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goo MJ, Ki MR, Lee HR, Yang HJ, Yuan DW,
Hong IH, Park JK, Hong KS, Han JY, Hwang OK, et al: Helicobacter
pylori promotes hepatic fibrosis in the animal model. Lab Invest.
89:1291–1303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito K, Nakamura M, Toda G, Negishi M,
Torii A and Ohno T: Potential role of Helicobacter pylori in
hepatocarcinogenesis. Int J Mol Med. 13:221–227. 2004.PubMed/NCBI
|
|
25
|
Ito K, Yamaoka Y, Ota H, El-Zimaity H and
Graham DY: Adherence, internalization, and persistence of
Helicobacter pylori in hepatocytes. Dig Dis Sci. 53:2541–2549.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Fan XG, Huang YK, Chen R and Dai
H: Helicobacter pylori enhances cyclin D1, PCNA expression in HepG2
cell line. Zhonghua Gan Zang Bing Za Zhi. 12:695–696. 2004.(In
Chinese). PubMed/NCBI
|
|
27
|
Chen R, Fan XG, Huang Y, Li N and Chen CH:
In vitro cytotoxicity of Helicobacter pylori on hepatocarcinoma
HepG2 cells. Ai Zheng. 23:44–49. 2004.(In Chinese). PubMed/NCBI
|
|
28
|
Karita M, Li Q, Cantero D and Okita K:
Establishment of a small animal model for human Helicobacter pylori
infection using germ-free mouse. Am J Gastroenterol. 89:208–213.
1994.PubMed/NCBI
|
|
29
|
Thalmaier U, Lehn N, Pfeffer K, Stolte M,
Vieth M and Schneider-Brachert W: Role of tumor necrosis factor
alpha in Helicobacter pylori gastritis in tumor necrosis factor
receptor 1-deficient mice. Infect Immun. 70:3149–3155. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Algood HM, Allen SS, Washington MK, Peek
RM Jr, Miller GG and Cover TL: Regulation of gastric B cell
recruitment is dependent on IL-17 receptor A signaling in a model
of chronic bacterial infection. J Immunol. 183:5837–5846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maurer KJ, Ihrig MM, Rogers AB, Ng V,
Bouchard G, Leonard MR, Carey MC and Fox JG: Identification of
cholelithogenic enterohepatic Helicobacter species and their role
in murine cholesterol gallstone formation. Gastroenterology.
128:1023–1033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee CW, Rickman B, Rogers AB, Muthupalani
S, Takaishi S, Yang P, Wang TC and Fox JG: Combination of sulindac
and antimicrobial eradication of Helicobacter pylori prevents
progression of gastric cancer in hypergastrinemic INS-GAS mice.
Cancer Res. 69:8166–8174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao X, Hu JF, Daniels M, Yien H, Lu H,
Sharan H, Zhou X, Zeng Z, Li T, Yang Y, et al: A novel orthotopic
tumor model to study growth factors and oncogenes in
hepatocarcinogenesis. Clin Cancer Res. 9:2719–2726. 2003.PubMed/NCBI
|
|
34
|
Aprahamian M, Bour G, Akladios CY,
Fylaktakidou K, Greferath R, Soler L, Marescaux J, Egly JM, Lehn JM
and Nicolau C: Myo-InositolTrisPyroPhosphate treatment leads to
HIF-1α suppression and eradication of early hepatoma tumors in
rats. Chem Biochem. 12:777–783. 2011.
|
|
35
|
Fox JG, Dewhirst FE, Shen Z, Feng Y,
Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, et
al: Hepatic Helicobacter species identified in bile and gallbladder
tissue from Chileans with chronic cholecystitis. Gastroenterology.
114:755–763. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leone N, Pellicano R, Brunello F, Cutufia
MA, Berrutti M, Fagoonee S, Rizzetto M and Ponzetto A: Helicobacter
pylori seroprevalence in patients with cirrhosis of the liver and
hepatocellular carcinoma. Cancer Detect Prev. 27:494–497. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ponzetto A, Pellicano R, Redaelli A,
Rizzetto M and Roffi L: Helicobacter pylori infection in patients
with hepatitis C Virus positive chronic liver diseases. New
Microbiol. 26:321–328. 2003.PubMed/NCBI
|
|
38
|
Spinzi G, Pellicano R, Minoli G, Terreni
N, Cutufia MA, Fagoonee S, Rizzetto M and Ponzetto A: Helicobacter
pylori seroprevalence in hepatitis C virus positive patients with
cirrhosis. The Como cross-sectional study. Panminerva Med.
43:85–87. 2001.PubMed/NCBI
|
|
39
|
Fan XG, Zou YY, Wu AH, Li TG, Hu GL and
Zhang Z: Seroprevalence of Helicobacter pylori infection in
patients with hepatitis B. Br J Biomed Sci. 55:176–178. 1998.
|
|
40
|
Zhang S, Bao Y and Zu MH: Research of
relationship between Hp infection and HCC. Chin J Clin Oncol.
45–48. 2004.
|
|
41
|
Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF
and Li N: Identification of helicobacter species in human liver
samples from patients with primary hepatocellular carcinoma. J Clin
Pathol. 57:1273–1277. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pellicano R, Mazzaferro V, Grigioni WF,
Cutufia MA, Fagoonee S, Silengo L, Rizzetto M and Ponzetto A:
Helicobacter species sequences in liver samples from patients with
and without hepatocellular carcinoma. World J Gastroenterol.
10:598–601. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Leelawat K, Suksumek N, Leelawat S and
Lek-Uthai U: Detection of VacA gene specific for Helicobactor
pylori in hepatocellular carcinoma and cholangiocarcinoma specimens
of Thai patients. Southeast Asian J Trop Med Public Health.
38:881–885. 2007.PubMed/NCBI
|
|
44
|
de Magalhaes Queiroz DM and Santos A:
Isolation of a Helicobacter strain from the human liver.
Gastroenterology. 121:1023–1024. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Matsukura N, Yokomuro S, Yamada S, Tajiri
T, Sundo T, Hadama T, Kamiya S, Naito Z and Fox JG: Association
between Helicobacter bilis in bile and biliary tract malignancies:
H. bilis in bile from Japanese and Thai patients with benign and
malignant diseases in the biliary tract. Jpn J Cancer Res.
93:842–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
García A, Feng Y, Parry NM, McCabe A,
Mobley MW, Lertpiriyapong K, Whary MT and Fox JG: Helicobacter
pylori infection does not promote hepatocellular cancer in a
transgenic mouse model of hepatitis C virus pathogenesis. Gut
Microbes. 4:577–590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rocha M, Avenaud P, Menard A, Le Bail B,
Balabaud C, Bioulac-Sage P, de Magalhães Queiroz DM and Mégraud F:
Association of Helicobacter species with hepatitis C cirrhosis with
or without hepatocellular carcinoma. Gut. 54:396–401. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hanninen ML: Sensitivity of Helicobacter
pylori to different bile salts. Eur J Clin Microbiol Infect Disy.
10:515–518. 1991. View Article : Google Scholar
|
|
49
|
Caldwell MT, McDermott M, Jazrawi S,
O'Dowd G, Byrne PJ, Walsh TN, Hourihane DO and Hennessy TP:
Helicobacter pylori infection increases following cholecystectomy.
Ir J Med Sci. 164:52–55. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kawaguchi M, Saito T, Ohno H, Midorikawa
S, Sanji T, Handa Y, Morita S, Yoshida H, Tsurui M, Misaka R, et
al: Bacteria closely resembling Helicobacter pylori detected
immunohistologically and genetically in resected gallbladder
mucosa. J Gastroenterol. 31:294–298. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Guyton JE and Hall AC: Textbook of Medical
Physiology. Saunders Elsevier; Philadelphia, PA: 2011
|
|
52
|
Kelly SM, Pitcher MC, Farmery SM and
Gibson GR: Isolation of Helicobacter pylori from feces of patients
with dyspepsia in the United Kingdom. Gastroenterology.
107:1671–1674. 1994.PubMed/NCBI
|
|
53
|
Thomas JE, Gibson GR, Darboe MK, Dale A
and Weaver LT: Isolation of Helicobacter pylori from human faeces.
Lancet. 340:1194–1195. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Narikawa S, Kawai S, Aoshima H, Kawamata
O, Kawaguchi R, Hikiji K, Kato M, Iino S and Mizushima Y:
Comparison of the nucleic acids of helical and coccoid forms of
Helicobacter pylori. Clin Diagn Lab Immunol. 4:285–290.
1997.PubMed/NCBI
|
|
55
|
Dore MP, Realdi G, Mura D, Graham DY and
Sepulveda AR: Helicobacter infection in patients with HCV-related
chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis
Sci. 47:1638–1643. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Silva LD, Rocha AM, Rocha GA, de Moura SB,
Rocha MM, Dani R, de Melo FF, Guerra JB, de Castro LP, Mendes GS,
et al: The presence of Helicobacter pylori in the liver depends on
the Th1, Th17 and Treg cytokine profile of the patient. Mem Inst
Oswaldo Cruz. 106:748–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Boonyanugomol W, Chomvarin C, Sripa B,
Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C and Chamsuwan A:
Helicobacter pylori in Thai patients with cholangiocarcinoma and
its association with biliary inflammation and proliferation. HPB
(Oxford). 14:177–184. 2012. View Article : Google Scholar
|
|
58
|
Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO,
Kim HJ, Park ET, Yoo KS, Lim BC, Seo DW, et al: Detection of
Helicobacter pylori DNA in human biliary tree and its association
with hepatolithiasis. Dig Dis Sci. 45:1405–1412. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen W, Li D, Cannan RJ and Stubbs RS:
Common presence of Helicobacter DNA in the gallbladder of patients
with gallstone diseases and controls. Dig Liver Dis. 35:237–243.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Silva CP, Pereira-Lima JC, Oliveira AG,
Guerra JB, Marques DL, Sarmanho L, Cabral MM and Queiroz DM:
Association of the presence of Helicobacter in gallbladder tissue
with cholelithiasis and cholecystitis. J Clin Microbiol.
41:5615–5618. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Maurer KJ, Rogers AB, Ge Z, Wiese AJ,
Carey MC and Fox JG: Helicobacter pylori and cholesterol gallstone
formation in C57L/J mice: A prospective study. Am J Physiol
Gastrointest Liver Physiol. 290:G175–G182. 2006. View Article : Google Scholar
|
|
62
|
Abayli B, Colakoglu S, Serin M, Erdogan S,
Isiksal YF, Tuncer I, Koksal F and Demiryurek H: Helicobacter
pylori in the etiology of cholesterol gallstones. J Clin
Gastroenterol. 39:134–137. 2005.PubMed/NCBI
|
|
63
|
Kowalski M, Rees W, Konturek PC, Grove R,
Scheffold T, Meixner H, Brunec M, Franz N, Konturek JW, Pieniazek
P, et al: Detection of Helicobacter pylori specific DNA in human
atheromatous coronary arteries and its association to prior
myocardial infarction and unstable angina. Dig Liver Dis.
34:398–402. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kusters JG, Gerrits MM, Van Strijp JA and
Vandenbroucke-Grauls CM: Coccoid forms of Helicobacter pylori are
the morphologic manifestation of cell death. Infect Immun.
65:3672–3679. 1997.PubMed/NCBI
|
|
65
|
Andersen LP, Dorland A, Karacan H, Colding
H, Nilsson HO, Wadström T and Blom J: Possible clinical importance
of the transformation of Helicobacter pylori into coccoid forms.
Scand J Gastroenterol. 35:897–903. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Tian XF, Fan XG, Fu CY, Huang Y and Zhu C:
Experimental study on the pathological effect of Helicobacter
pylori on liver tissues. Zhonghua Gan Zang Bing Za Zhi. 13:780–783.
2005.(In Chinese). PubMed/NCBI
|
|
67
|
Egelkrout EM, Mariconti L, Settlage SB,
Cella R, Robertson D and Hanley-Bowdoin L: Two E2F elements
regulate the proliferating cell nuclear antigen promoter
differently during leaf development. Plant Cell. 14:3225–3236.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Essers J, Theil AF, Baldeyron C, van
Cappellen WA, Houtsmuller AB, Kanaar R and Vermeulen W: Nuclear
dynamics of PCNA in DNA replication and repair. Mol Cell Biol.
25:9350–9359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shivji KK, Kenny MK and Wood RD:
Proliferating cell nuclear antigen is required for DNA excision
repair. Cell. 69:367–374. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Leonardi E, Girlando S, Serio G, Mauri FA,
Perrone G, Scampini S, Dalla Palma P and Barbareschi M: PCNA and
Ki67 expression in breast carcinoma: correlations with clinical and
biological variables. J Clin Pathol. 45:416–419. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kobayashi I, Matsuo K, Ishibashi Y, Kanda
S and Sakai H: The proliferative activity in dysplasia and
carcinoma in situ of the uterine cervix analyzed by proliferating
cell nuclear antigen immunostaining and silver-binding argyrophilic
nucleolar organizer region staining. Hum Pathol. 25:198–202. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Allegranza A, Girlando S, Arrigoni GL,
Veronese S, Mauri FA, Gambacorta M, Pollo B, Dalla Palma P and
Barbareschi M: Proliferating cell nuclear antigen expression in
central nervous system neoplasms. Virchows Arch A Pathol Anat
Histopathol. 419:417–423. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tsai ST and Jin YT: Proliferating cell
nuclear antigen (PCNA) expression in oral squamous cell carcinomas.
J Oral Pathol Med. 24:313–315. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Willett CG1, Warland G, Hagan MP, Daly WJ,
Coen J, Shellito PC and Compton CC: Tumor proliferation in rectal
cancer following preoperative irradiation. J Clin Oncol.
13:1417–1424. 1995.PubMed/NCBI
|
|
75
|
Prosperi E: Multiple roles of the
proliferating cell nuclear antigen: DNA replication, repair and
cell cycle control. Prog Cell Cycle Res. 3:193–210. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Moldovan GL, Pfander B and Jentsch S:
PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang SC, Nakajima Y, Yu YL, Xia W, Chen
CT, Yang CC, McIntush EW, Li LY, Hawke DH, Kobayashi R and Hung MC:
Tyrosine phosphorylation controls PCNA function through protein
stability. Nat Cell Biol. 8:1359–1368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Pal HC1, Sharma S, Strickland LR, Agarwal
J, Athar M, Elmets CA and Afaq F: Delphinidin reduces cell
proliferation and induces apoptosis of non-small-cell lung cancer
cells by targeting EGFR/VEGFR2 signaling pathways. PLoS One.
8:e772702013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Aziz MH, Wheeler DL, Bhamb B and Verma AK:
Protein kinase C delta overexpressing transgenic mice are resistant
to chemically but not to UV radiation-induced development of
squamous cell carcinomas: A possible link to specific cytokines and
cyclo-oxygenase-2. Cancer Res. 66:713–722. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ojeh N, Hiilesvuo K, Warri A, Salmivirta
M, Henttinen T and Maatta A: Ectopic expression of syndecan-1 in
basal epidermis affects keratinocyte proliferation and wound
re-epithelialization. J Invest Dermatol. 128:26–34. 2008.
View Article : Google Scholar
|
|
81
|
Tian XF, Fan XG, Huang Y, Zhang Y and Zhu
C: Expression of cyclin D1 proliferating cell nuclear antigen in
liver of C57BL/6 mice infected with Helicobacter pylori. World Chin
J Digestol. 14:1341–1345. 2006.
|
|
82
|
Zhang Y, Fan XG, Chen R, Xiao ZQ, Feng XP,
Tian XF and Chen ZH: Comparative proteome analysis of untreated and
Helicobacter pylori-treated HepG2. World J Gastroenterol.
11:3485–3489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Komatsu K1, Miyashita T, Hang H, Hopkins
KM, Zheng W, Cuddeback S, Yamada M, Lieberman HB and Wang HG: Human
homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes
apoptosis. Nat Cell Biol. 2:1–6. 2000.PubMed/NCBI
|
|
84
|
Lin B, Kolluri SK, Lin F, Liu W, Han YH,
Cao X, Dawson MI, Reed JC and Zhang XK: Conversion of Bcl-2 from
protector to killer by interaction with nuclear orphan receptor
Nur77/TR3. Cell. 116:527–540. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Hoetelmans RW: Nuclear partners of Bcl-2:
Bax and PML. DNA Cell Biol. 23:351–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tsujimoto Y, Finger LR, Yunis J, Nowell PC
and Croce CM: Cloning of the chromosome breakpoint of neoplastic B
cells with the t(14;18) chromosome translocation. Science.
226:1097–1099. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cleary ML, Smith SD and Sklar J: Cloning
and structural analysis of cDNAs for bcl-2 and a hybrid
bcl-2/immunoglobulin transcript resulting from the t(14;18)
translocation. Cell. 47:19–28. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yang LJ, Cao XT and Yu LZ: Bcl-2 and Bax
in apoptosis of tumor cells. Chin J Cancer Biother. 10:232–234.
2003.
|
|
90
|
Yin XM, Oltvai ZN and Korsmeyer SJ: BH1
and BH2 domains of Bcl-2 are required for inhibition of apoptosis
and heterodimerization with Bax. Nature. 369:321–323. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yang E and Korsmeyer SJ: Molecular
thanatopsis: a discourse on the BCL2 family and cell death. Blood.
88:386–401. 1996.PubMed/NCBI
|
|
92
|
Yang E, Zha J, Jockel J, Boise LH,
Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for
Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell.
80:285–291. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Cotran RS, Kumar V and Collins T: Robbins
Pathologic Basis of Disease. 6th edition. W.B Saunders Company;
Philadelphia, PA: 1998
|
